Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Baseline characteristics of all those randomised to the dietary support (DS) and social support (SS) groups

From: A randomised controlled trial of dietary improvement for adults with major depression (the ‘SMILES’ trial)

  Total (n = 67) DS (n = 33) SS (n = 34)
Demographic
 Gender % female % (n) 71.6 (48) 81.8 (27) 61.8 (21)
 Age M (SD) 40.3 (13.1) 37.5 (10.7) 43.1 (14.6)
 Post-secondary school education % (n) 51.5 (34) 51.5 (17) 51.5 (17)
Household income
 Above $80,000 per annum % (n) 23.1 (15) 25.0 (8) 21.2 (7)
Health measures
 BMI M (SD) 29.5 (8.0) 30.0 (9.3) 29.0 (6.5)
 Current smoker % (n) 14.1 (9) 10.0 (3) 17.6 (6)
 Comorbid disorder % (n) 71.2 (47) 75.0 (24) 67.6 (23)
 Number of comorbid disorders M (SD) 1.5 (1.4) 1.6 (1.4) 1.5 (1.4)
 Physical activity (IPAQ score) M (SD) 2336 (2585) 2146 (2565) 2509 (2629)
Current treatments
 Psychopharmacotherapy % (n) 68.7 (46) 75.8 (25) 61.8 (21)
 Psychological therapy % (n) 44.8 (30) 39.4 (13) 50.0 (17)
Diet quality
 Screen of diet quality M (SD) 51.2 (11.0) 48.5 (10.3) 53.9 (11.3)
 ModiMedDiet (0-120) M (SD) 41.5 (14.3) 36.2 (12.8) 47.3 (13.7)
Psychological measures
 MADRS (0-60) M (SD) 25.4 (4.6) 26.1 (4.9) 24.7 (4.2)
 HADS – (D) (0-21) M (SD) 9.6 (3.7) 10.0 (4.0) 9.2 (3.4)
 HADS – (A) (0-21) M (SD) 11.7 (3.0) 12.1 (3.1) 11.2 (2.8)
  1. BMI body mass index, MADRS Montgomery-Åsberg Depression Rating Scale, HADS Hospital Anxiety and Depression Scale